AVIR
Atea Pharmaceuticals Inc
Price:  
2.93 
USD
Volume:  
256,573.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atea WACC - Weighted Average Cost of Capital

The WACC of Atea Pharmaceuticals Inc (AVIR) is 8.3%.

The Cost of Equity of Atea Pharmaceuticals Inc (AVIR) is 11.60%.
The Cost of Debt of Atea Pharmaceuticals Inc (AVIR) is 5.00%.

Range Selected
Cost of equity 9.70% - 13.50% 11.60%
Tax rate 0.50% - 1.70% 1.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.3% - 9.2% 8.3%
WACC

Atea WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.26 1.54
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.70% 13.50%
Tax rate 0.50% 1.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.3% 9.2%
Selected WACC 8.3%